Can we image the "active" thrombus?

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 11, 2002, Pages 1753-1754

  Badimon, Juan Jose ^a   Fuster, Valentin ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGATROBAN; FIBRIN; FIBRINOGEN; HIRUDIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN; THROMBIN INHIBITOR;

ATHEROSCLEROSIS; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; EDITORIAL; HEART INFARCTION; HUMAN; MOLECULAR PROBE; NONHUMAN; PRIORITY JOURNAL; THROMBOGENESIS; THROMBUS;

ANTITHROMBINS; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; RANDOMIZED CONTROLLED TRIALS; THROMBIN; THROMBOSIS; TREATMENT OUTCOME;

EID: 0036846918     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000041841.81842.14     Document Type: Editorial

References (5)

1. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients: Antiplatelet Trialist's Collaboration. Brit Med J. 2002;324:71-86.
2. Direct thrombin inhibitors in acute coronary syndromes: Principal results of a meta-analysis based on individual patients' data. Lancet. 2002;359:294-302.
3. Jaffer AF, Tung C-H, Gerszten RE, Weissleder R. In vivo imaging of thrombin activity in experimental thrombi using a thrombin-sensitive near-infrared molecular probe. Arterioscler Thromb Vasc Biol. 2002;22:1929-1935.
4. Robinson BR, Houng AK, Reed GL. Catalytic life of activated factor XIII in thrombi: Implications for fibrinolytic resistance and thrombus aging. Circulation. 2000;102:1151-1157.
5. Corti R, Osende JI, Fayad ZA, Fallon JT, Fuster V, Mizsei G, Dickstein E, Drayer B, Badimon JJ. In vivo noninvasive detection and age definition of arterial thrombus by MRI. J Am Coll Cardiol. 2002;39:1366-1373.